Canada’s Leading Pricing and Reimbursement Consultancy
Established in 1996, PDCI Market Access is Canada’s leading pricing and reimbursement consultancy. PDCI features over twenty staff, including experienced bilingual consultants and analysts. Headquartered in Ottawa, PDCI also has several consultants based in the Toronto area.
PDCI prides itself on being the only Canadian consultancy with core competencies and expertise in both pricing and reimbursement. We are a client focused, mid-size consultancy large enough to address any contingencies, but small enough that senior staff work directly with our clients on all projects. PDCI has significant support infrastructure, including claims and price databases, scientific resources, and market intelligence.
We help Pharma/Biotech firms:
PDCI’s Projects Include:
PIVINA Consulting Inc. is an innovative and energetic company with core capabilities in market access, reimbursement strategies, and health economic evaluations with extensive submission experience to public and private payers, such as the CDR, pCODR, and INESSS. PIVINA’s experience also includes developing and implementing overall clinical and economic strategies for these products AND additional analytical capabilities in support of reimbursement. Further, PIVINA has had the opportunity to work on numerous product listing agreements and have worked on ~20 products that have either gone through pCPA or are currently under pCPA review; thus, provide clients with added value and support through this new process.
Life sciences companies around the world turn to Charles River Associates (CRA) when they need clear analysis and pragmatic solutions to the industry’s most complex issues. As a leading global consulting firm, CRA offers clients deep industry knowledge, rigorous analytic techniques, and decades of experience in thousands of successful engagements. CRA’s hands-on senior-level team combines skills that span geographies and therapeutic areas to develop tailored approaches based on our clients’ unique needs. Our expertise in pricing and market access strategy helps clients achieve optimal value for their shareholders and maximize the potential of their products.
Certara Evidence & Access – Driving Impactful Science from Bench to Market. We’re providing unparalleled end-to-end strategy and cutting-edge technology to define, capture, and communicate value. Our teams are recognized for combining the highest quality evidence and strategic insights on therapeutic value with deep relationships in the payer community.
Innomar Strategies, part of AmerisourceBergen, is the leading service provider in the Canadian specialty biopharmaceutical market. We deliver end-to-end commercialization solutions to improve product access, increase supply chain efficiency and enhance patient care. Innomar’s integrated services include:
• Consulting services
• Patient support programs
• Nursing and clinical services
• Specialty pharmacy and logistics
We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to patient care, Innomar Strategies helps manufacturers optimize product performance in the complex Canadian healthcare environment.